Results 131 to 140 of about 6,369 (156)

Pharmacokinetic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trial

Annals of Hematology, 2010
Cornelius F Waller, Waller Cornelius F
exaly  

Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy

Lancet, The, 1992
William P Sheridan, R M Fox, D Maher
exaly  

Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim inchemotherapy-induced neutropenia: a multicenterdose-finding study in women with breast cancer

Annals of Oncology, 2002
F A Holmes, S Vukelja, D R Budman
exaly  

Filgrastim

Reactions Weekly, 1993
openaire   +1 more source

Filgrastim

Reactions Weekly, 1994
openaire   +1 more source

Filgrastim

Reactions Weekly, 2008
openaire   +2 more sources

Comparison of the pharmacodynamic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trial

Annals of Hematology, 2010
Cornelius F Waller, Waller Cornelius F
exaly  

Tbo-Filgrastim: A Review in Neutropenic Conditions

BioDrugs, 2016
Hannah A Blair, Blair Hannah A, Scott Lesley J   +2 more
exaly  

Filgrastim

Reactions Weekly, 2000
openaire   +1 more source

Biosimilar Filgrastim Uptake And Costs Among Commercially Insured, Medicare Advantage

Health Affairs, 2019
Pinar Karaca-Mandic, Ronald S Go, Daniel J Weisdorf   +2 more
exaly